Cramer's 'Mad Money' Recap: Go to the Dogs

 

Click here for an archive of Cramer's "Mad Money" recaps.


"Buy Rite Aid (RAD), Jim Cramer told "Mad Money" TV viewers Wednesday, a company that he always says to stay away from.

"If you do want to go out and find an absolutely worst of breed pharmacy, you're always going to end up with Rite Aid," Cramer said. "But when the bull market is upon us, we break the rules and buy worst of breed."

Cramer said that the "unquestionable bull market in the pharmacies" is what makes Rite Aid right.

"I hate Rite Aid. ... I just want you to buy it," he said.

It's sexy now for all the same reasons he's been recommending best of breed Walgreen(WAG) and CVS(CVS), and it's all about Medicare Part D, Cramer said.

This is because the new legislation encourages people to buy generic drugs, which translates into more money for pharmacies as the government drops $400 million on drug spending, Cramer said.

So why buy Rite Aid when there are best of breed players out there? You've missed nothing with Rite Aid, he said, adding that it's extremely cheap next to the competition.

Rite Aid closed Wednesday's regular session at $3.89.

And Rite Aid had positive same-store sales for the first time, Cramer said, adding that "you've got a stock here for the first time in a long time that might rally for good reasons."

Moreover, a Goldman Sachs analyst has upgraded the stock, he said.

Take a Gamble

We have no choice but to go where the money is ... and that means going to China, Cramer said.

But, as always, he said to steer clear of Chinese companies and to buy American companies that profit off the quirks of the Chinese. In this case, he said it's time to make some money from the fact that the Chinese are gambling again.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,883.95 1,349.96 2,915.86 20.52
Oil *
118.49
UP
5.75
UP
2.91
UP
11.78
UP
0.77
10 Yr
2.05%
SPDR Gold
168.50
+0.04%
+0.22%
+0.41%
+3.90%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet